Strategies for Treatment of Thyroid Cancer

被引:4
|
作者
Yadav, Deepika [1 ]
Sharma, Pramod Kumar [1 ]
Malviya, Rishabha [1 ]
Mishra, Prem Shankar [1 ]
机构
[1] Galgotias Univ, Sch Med & Allied Sci, Dept Pharm, Greater Noida, Uttar Pradesh, India
关键词
Thyroid cancer; radioactive iodine; molecular therapy; ablation treatment; thyroidectomy; novel target therapy; RET/PTC ONCOGENE ACTIVATION; PHASE-II TRIAL; RET PROTOONCOGENE; PAPILLARY CARCINOMAS; CURRENT DIAGNOSIS; KINASE INHIBITOR; HIGH-FREQUENCY; RAS; REARRANGEMENTS; TUMORS;
D O I
10.2174/1389450124666230222093308
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
More people are diagnosed with thyroid cancer than any other endocrine tumor. Differentiated thyroid cancer is often treated by removing the thyroid gland (thyroidectomy), iodizing radiation, or inhibiting thyroid stimulating hormone (TSH). Advanced thyroid carcinomas are notoriously resistant to chemotherapy, thus the pursuit of alternative treatments is vital. The best methods for treating individuals with advanced nonmedullary and medullary thyroid carcinomas are discussed in this post. Numerous tyrosine kinase inhibitors and antiangiogenic inhibitors, two types of novel target therapy, have shown promise in studies for individuals with thyroid cancer. Both the positive and unfavourable outcomes of clinical studies of these drugs were addressed. The findings presented here are encouraging, but more study is required to establish whether or not this method is effective in the treatment of thyroid cancer.
引用
收藏
页码:406 / 415
页数:10
相关论文
共 50 条
  • [41] Sunitinib in the Treatment of Thyroid Cancer
    Ferrari, Silvia Martina
    Centanni, Marco
    Virili, Camilla
    Miccoli, Mario
    Ferrari, Paola
    Ruffilli, Ilaria
    Ragusa, Francesca
    Antonelli, Alessandro
    Fallahi, Poupak
    CURRENT MEDICINAL CHEMISTRY, 2019, 26 (06) : 963 - 972
  • [42] SURGICAL TREATMENT FOR THYROID CANCER
    EDIS, AJ
    SURGICAL CLINICS OF NORTH AMERICA, 1977, 57 (03) : 533 - 542
  • [43] TREATMENT OF INCIDENTAL THYROID CANCER
    SIMONOWITZ, D
    THOMSEN, S
    MOOSSA, AR
    BLOCK, GE
    ARCHIVES OF SURGERY, 1976, 111 (04) : 477 - 483
  • [44] The treatment of differentiated thyroid cancer
    Hubold, C.
    Buchmann, I.
    Lehnert, H.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (17) : 891 - 895
  • [45] Radioiodine in the treatment of thyroid cancer
    Van Nostrand, Douglas
    Wartofsky, Leonard
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2007, 36 (03) : 807 - +
  • [46] TREATMENT OF THYROID-CANCER
    EDMONDS, CJ
    CLINICS IN ENDOCRINOLOGY AND METABOLISM, 1979, 8 (01): : 223 - 242
  • [47] Antiangiogenic TKIs and Advanced RAI-Resistant Thyroid Cancer: Time for Rethinking Treatment Strategies?
    Licitra, Lisa
    Locati, Laura
    THYROID, 2014, 24 (12) : 1815 - 1815
  • [48] Action of thyroid hormones in sorafenib treatment of thyroid cancer
    Campos Haedo, Mateo N.
    Diaz Flaque, Maria C.
    Sterle, Helena A.
    Diaz Albuja, Johanna A.
    Cayrol, Maria F.
    Debernardi, Maria M.
    Perona, Marina
    Juvenal, Guillermo J.
    Cremaschi, Graciela A.
    Rosemblit, Cinthia
    CANCER RESEARCH, 2023, 83 (07)
  • [49] Challenges and strategies on radioiodine treatment for differentiated thyroid carcinoma
    Cheng, Lingxiao
    Liu, Min
    Ruan, Maomei
    Chen, Libo
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2016, 19 (01) : 23 - 32
  • [50] CURRENT STRATEGIES FOR DIAGNOSIS AND TREATMENT OF THYROID-CARCINOMA
    BENKER, G
    REINERS, C
    KRAUSE, U
    BAMBERG, M
    REINWEIN, D
    INTERNIST, 1988, 29 (08): : 564 - 569